Delivery Order SPE2DB22D3501-SPE2DB24FUD11

Award Date 1/11/24
Potential Completion Date 1/12/24
Potential Value $4.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $4,348.32 and a completion date of February 13, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor serving federal government agencies. The contract has a ceiling value of $6,802.72 and an ultimate completion date of December 1, 2023. It is a delivery order contract with a firm fixed price pricing...
This federal contract award is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 12, 2024, with a completion date of December 13, 2024. The contract has a ceiling value of $13,022.30 and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation....
This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,527.07, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on December 27, 2023 with a completion date of December 28, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of Fluticasone Prop HFA 220 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,121.75 contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 13, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC enables the DLA to...
This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, on April 2, 2024 as a firm fixed price delivery order under an existing indefinite delivery contract (IDC) with a potential value of up to...
The federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,280.62 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order with an ultimate completion date of September 13, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $1,356.33 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 15, 2024, with a completion date of March 18, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to...
This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,112.49, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract has an ultimate completion date of November 7, 2023 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up...
This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,144.02 and is a firm fixed-price delivery order, with an ultimate completion date of November 25, 2024. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FUD11
    Delivery Order

This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company.

The contract is a delivery order with a firm fixed price of $4,461.37 and a completion date of January 12, 2024. It is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/13/25, 10:05 AM